Recruit Rockstars 350: Telemedicine is Alive & Well (…And His New IPO Proves It)

It took me a long time to finally book this guest. And it was worth the wait.

Dr Roy Schoenberg is Co-Founder and CEO of Amwell, the transformative telemedicine company that IPO’d last month.

After serving in the Israel Defense Forces & earning his MD, Roy co-founded the company (originally American Well) with his brother in 2006.

It’s become one of the largest most important telemedicine & telehealth companies in the world

Amwell connects on-demand telehealth visits between patients in need & available providers. Once just a scrappy startup, the Amwell ecosystem has attracted 200 of the nation’s largest payers, health systems, employers, retailers and reaches 80 million Americans as a covered benefit.

Prior to Amwell, Roy was Founder of CareKey & CISO of TriZetto, following its acquisition of CareKey. Roy is the recipient of the American Telemedicine Association Industry award for leadership in the field of telemedicine.

This year has been transformative for Amwell. Usage is up 3,000% since the pandemic began. It’s convenient, intimate, and avoids costly ER visits.

On its journey, Amwell raised $800M from Allianz X, Takeda, Inventure Partners, and Google Cloud.

Then, the Coronavirus set the business on fire.

And on Sep 17, 2020, the company went public.

In this 20-minute conversation, Roy reveals how he overcame the odds & skepticism. And how he’s scaled the team to 1,000 full-time employees + 10,000 clinicians.